Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Astellas Promotes Shontelle Dodson to Sr. VP & Head of Medical Affairs Americas

By Astellas | May 12, 2017

Astellas names Shontelle Dodson Senior Vice President and Head of Medical Affairs Americas.

Astellas announced the promotion of Shontelle Dodson, Pharm.D., to senior vice president and head of Medical Affairs Americas, effective May 15, 2017. Dodson previously served as vice president of Medical Excellence within the global Medical Affairs organization.

“Shontelle has been an integral and formative leader in the building and evolution of the Medical Affairs organization at Astellas,” said Charlotte Kremer, M.D., executive vice president and head, Medical Affairs, Astellas. “I’m confident she will make an immediate and positive impact on both the team in the Americas, as well as the patients and partners we serve.”

In Dodson’s most recent role, she led the alignment of Medical Affairs practices, policies and standards across the globe – including the launch of global systems to manage Medical Communications, Publications and Investigator Sponsored Research (ISR). During her time at Astellas, she has also expanded the Health Economics & Outcomes Research function and pioneered multiple, innovative real world data projects and research partnerships with leading managed care and academic organizations.

In her new role, Dodson will report directly to Kremer and assume overall responsibility for the strategic direction of the Medical Affairs Americas organization, including continued medical support of in-line products, late-stage development compounds and ongoing business evolution across the region.

Dodson has extensive clinical and research experience in the healthcare and pharmaceutical industries. After starting her career in direct patient care at the Department of Veterans Affairs, Dodson spent more than a decade at Pfizer in various Medical Affairs leadership roles spanning the urology and respiratory franchises. Following her work with Pfizer, Dodson then served as vice president of Medical Affairs at GTx, Inc., where she led a Phase 3 clinical development study of a selective androgen receptor modulator for the prevention and treatment of muscle wasting in patients with cancer. She also incorporated key economic and health outcomes assessments to support product utilization and valuation. 

Dodson has received multiple awards for leadership and innovation throughout her career, including the National Healthcare Business Women’s Association Rising Star and the Astellas Vision Award. She earned a doctorate of pharmacy degree from Mercer University School of Pharmacy and completed a postdoctoral residency at the Department of Veterans Affairs Medical Center in Nashville, Tenn.

(Source: Astellas)

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!


Filed Under: Drug Discovery

 

Related Articles Read More >

Ball-and-stick model of the cancer drug imatinib
After six years in stealth, Humanitas bets on hybrid AI for drug discovery
NIH is reorganizing clinical trial funding by trial type instead of disease
Chemical formula of psilocybin
Psychedelic pioneer Compass files for FDA approval as rivals close in
Insilico’s AI-designed TEAD inhibitor shrank tumors in 4 of 22 mesothelioma patients; randomized Phase 2a planned for 2027
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE